Medical characteristics of the oldest old: retrospective chart review of patients aged 85+ in an academic primary care centre

BMC Research Notes

Ross EG Upshur⁴  Li Wang³  C Shawn Tracy¹  Jason X Nie¹  Hiu-Wah Li²  Kenny S Choi²  Justin Y Chow⁴  Christopher S Tsoi⁵ 

[1] Bridgepoint Active Healthcare, Toronto M4M 2B5, ON, Canada;Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto M4N 3 M5, ON, Canada;Cancer Care Ontario, Toronto M5G 2 L3, ON, Canada;Faculty of Medicine, University of Toronto, Toronto M5S 1A8, ON, Canada;Mount Sinai Hospital Sherman Health and Wellness Centre, 9600 Bathurst Street, Suite 300, Vaughan L6A3Z8, ON, Canada

关键词: Multimorbidity;    Geriatrics;    Primary care;   

Others  :  1132583
DOI  :  10.1186/1756-0500-7-340

 received in 2013-09-09, accepted in 2014-05-30,  发布年份 2014

【 摘 要 】

Background

The population aged 85 + − the “oldest old” – is now the fastest growing age segment in Canada. Although existing research demonstrates high health services utilization and medication burden in this population, little clinically derived evidence is available to guide care. This is a descriptive study in a primary care context seeking to describe the most common health conditions and medications used in the “oldest old”.

Methods

We conducted a retrospective chart review of all family practice patients aged 85+ (N = 564; 209 males, 355 females) at Sunnybrook Health Sciences Centre in Toronto, Canada. Electronic medical records were reviewed for all current chronic conditions and medication prescriptions, and then stratified by sex and age subgroup (85–89, 90–94, 95+) for descriptive analysis.

Results

On average, patients experienced 6.4 concurrent chronic conditions and took 6.8 medications. Most conditions were related to cardiovascular (79%) and bone health (65%). Hypertension (65%) was the most common condition. Bone-related conditions (e.g. osteoarthritis, osteoporosis) and hypothyroidism predominantly affected women, while coronary artery disease and type 2 diabetes were more prevalent in men. The top two prescribed medications were atorvastatin (33%) and aspirin 81 mg (33%). Males were more likely to be prescribed lipid-lowering medications, while females were more likely to receive osteoporosis therapy. Patients received less lipid-lowering therapy with increasing age.

Conclusions

Multimorbidity and polypharmacy are highly prevalent in patients in the 85+ age group. The most common clinical conditions are related to cardiovascular and bone health, and the most commonly prescribed medications are directed towards risk factors for these illnesses. In the absence of data to guide clinical decision-making, this study provides a first look at the common health concerns and medication profiles in this population and reveals trends that give rise to reflections on how clinical care for these patients can be improved.

【 授权许可】

   
2014 Tsoi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Statistics Canada: The Canadian population in 2011: age and sex. http://www12.statcan.gc.ca/census-recensement/2011/as-sa/98-311-x/98-311-x2011001-eng.cfm webcite
• [2]Vegda K, Nie JX, Wang L, Tracy CS, Moineddin R, Upshur RE: Trends in health services utilization, medication use, and health conditions among older adults: a 2-year retrospective chart review in a primary care practice. BMC Health Serv Res 2009, 9:217. BioMed Central Full Text
• [3]Nie JX, Wang L, Tracy CS, Moineddin R, Upshur RE: Health care service utilization among the elderly: findings from the Study to Understand the Chronic Condition Experience of the Elderly and the Disabled (SUCCEED project). J Eval Clin Pract 2008, 14(6):1044-1049.
• [4]Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur RE: From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997–2006. BMC Fam Pract 2010, 11:75. BioMed Central Full Text
• [5]Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012, 380(9836):37-43.
• [6]Kirchberger I, Meisinger C, Heier M, Zimmermann A, Thorand B, Autenrieth C, Peters A, Ladwig K, Döring A: Patterns of multimorbidity in the aged population. results from the KORA-Age study. PLoS One 2012, 7(1):e30556.
• [7]Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H: A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med 2012, 10(2):142-151.
• [8]Manuel DG, Maaten S, Thiruchelvam D, Jaakkimainen L, Upshur R: Primary Care in Ontario. Toronto: Institute of Clinical Evaluative Sciences; 2006.
• [9]Upshur RE, Wang L, Moineddin R, Nie JX, Tracy CS: The complexity score: towards a clinically-relevant, clinician-friendly measure of patient multi-morbidity. Int J Pers Cent Med 2012, 2(4):799-804.
• [10]Lewis J: Cumulative patient profile. Can Fam Physician 1989, 35:1259-1261.
• [11]Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE: Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism 2006, 55(1):78.
• [12]Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR: Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002). Thyroid 2007, 17(12):1211-1223.
• [13]Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111(2):383.
• [14]Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW: Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005, 294(6):716-724.
• [15]Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW: Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161(13):1629.
• [16]Lee SJ, Leipzig RM, Walter LC: Incorporating lag time to benefit into prevention decisions for older adults. JAMA 2013, 310(24):2609-2610.
• [17]Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diab 2013, 37(suppl 1):S1-S212.
• [18]Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A: Socioeconomic status and cardiovascular disease: risks and implications for care. Cardiology 2009, 6(11):712-722.